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Background:  The  main  disadvantage  of  the  surgical  management  of  early  onset  scoliosis  (EOS)  using
conventional  growing  rods  is the  need  for  iterative  surgical  procedures  during  childhood.  The  emergence
of  an  innovative  device  using  distraction-based  magnetically  controlled  growing  rods  (MCGR)  provides
the  opportunity  to avoid  such  surgeries  and therefore  to improve  the  patient’s  quality  of life.
Hypothesis:  Despite  the  high  cost of  MCGR  and  considering  its  potential  impact  in reducing  hospital
stays,  the  use  of  MCGR  could  reduce  medical  resource  consumption  in  a  long-term  view  in comparison
to  traditional  growing  rod  (TGR).
Materials  and methods:  A cost-simulation  model  was  constructed  to assess  the  incremental  cost  between
the  two strategies.  The  cost  for each  strategy  was  estimated  based  on  probability  of medical  resource
consumption  determined  from  literature  search  as well  as data  from  EOS  patients  treated  in our  centre.
Some  medical  expenses  were  also  estimated  from  expert  interviews.  The  time  horizon  chosen  was  4  years
as  from  ﬁrst  surgical  implantation.  Costs  were  calculated  in the perspective  of the  French  sickness  fund
(using  rates from  year  2013)  and  were  discounted  by  an  annual  rate  of 4%.  Sensitivity  analyses  were
conducted  to  test  model  strength  to various  parameters.
Results: With  a time  horizon  of  4 years,  the  estimated  direct  costs  of  TGR  and  MCGR  strategies  were
49,067  D  and  42,752  D, respectively  leading  to an  incremental  costs  of 6135  D in favour  of  MCGR  strategy.
In  the ﬁrst  case,  costs  were  mainly  represented  by  hospital  stays  expenses  (83.9%)  whereas  in  the  other
the cost  of  MCGR  contributed  to  59.5%  of  the total  amount.  In the  univariate  sensitivity  analysis,  the  tariffs
of  hospital  stays,  the  tariffs  of the  MCG,  and  the  frequency  of  distraction  surgeries  were  the parameters
with  the  most  important  impact  on incremental  cost.
Discussion:  MCGR  is  a recent  and  promising  innovation  in the  management  of severe  EOS.  Besides  improv-
ing  the  quality  of life,  its use  in  the  treatment  of  severe  EOS  is  likely to  be offset  by lower  costs  of  hospital
stays.
Level  of evidence  (with  study  design):  Level  IV,  economic  and  decision  analyses,  retrospective  study.
©  2014  Elsevier  Masson  SAS.  All  rights  reserved.∗ Corresponding author at: Groupement Hospitalier Est, Hospices Civils de Lyon,
venue du Doyen-Lépine, 69500 Bron, France. Tel.: +33 4 72 35 72 45.
E-mail address: xavier.armoiry@chu-lyon.fr (X. Armoiry).
http://dx.doi.org/10.1016/j.otsr.2014.05.006
877-0568/© 2014 Elsevier Masson SAS. All rights reserved.1. BackgroundEarly onset scoliosis (EOS) has the potential to induce major
spinal deformity, which can lead to cardio-thoracic insufﬁciency
syndrome and result in poor prognosis if untreated [1,2]. Its man-
agement remains challenging since therapeutic approach aims at
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considered for spinal bracing, physiotherapy visits, and medical
transportation.
All the assumptions concerning medical resource expenses are70 C. Charroin et al. / Orthopaedics & Trauma
educing and controlling the spinal curvature while maintaining
rowth of spine and thorax [3]. Until spinal fusion is indicated,
he current gold standard for severe EOS management when
rthopaedic management has failed is the surgical implantation
f spinal growing rods. Non-fusion instrumented surgery reduces
he curvature and maintains the correction by iterative distraction
urgeries [4]. Although effective, EOS surgeries using traditional
rowing rods (TGR) can lead to several complications and affect
he quality of life due to the number of surgical procedures and
ospitalizations [5–7].
Some new systems have been developed to obtain a stable cor-
ection of spinal curvature while avoiding repetitive surgeries using
istraction-based magnetically controlled growing rods (MCGR)
8,9].
An MCGR system was recently CE marked and is available in
uropean countries but its use is limited as the substantial cost
f this innovative device is not currently supported by Healthcare
ystems [10].
Despite the cost and considering the potential impact of MCGR
n reducing hospital stays, we hypothesized that the use of MCGR
ould reduce medical resource consumption in a long-term view
n comparison to TGR. Since no study reporting current costs of
OS management using TGR is available, a cost analysis was per-
ormed based on French healthcare perspective in order to evaluate
hether MCGR could be cost saving compared to TGR.
. Methods
The case of a young patient, presenting severe early onset sco-
iosis (Cobb angle superior to 45◦), progressing despite optimal
onservative treatment (progression of the curvature of > 5◦ over
 twelve-month period), for whom a fusionless surgery strategy,
ither with TGR or MCGR, is decided, was considered regardless of
OS etiology.
A cost-simulation model was constructed to compare the esti-
ated long-term cost between TGR and MCGR with limitation to
irect costs.
Cost analysis was performed in the perspective of the French
ational Sickness Fund. Indeed, the French health care system is
haracterized by its social insurance system with full support in
anagement of severe disabling conditions such as spinal deformi-
ies. The time horizon chosen was 4 years as from the ﬁrst surgical
rocedure. All costs were expressed in euros (D), were calculated
sing rates from year 2013, and were discounted by an annual
ate of 4% as recommended by the French National Authority for
ealth’s guidelines [11].
.1. Medical resource expenses for TGR strategy
Medical resource expenses were estimated on the basis of data
rom a cohort of EOS patients treated in our centre (Hôpital Femme-
ère–Enfant, Lyon, France) with TGR between 2003 and 2010 and
ollow-up after index surgery – TGR implantation – for at least
2 months. Clinical data and medical expenses were retrospectively
ollected from those patient medical records and from the hospi-
al information system. The mean number and duration of hospital
tays, the type of instrumentation implanted, as well as the mean
umber of medical consultations and radiographs were considered.
ight patients (6 boys, 2 girls) with a mean age at ﬁrst surgery
f 5.9 ± 2.6 years were selected. All EOS were non-idiopathic with
arious etiologies: neurologic (38%), syndromic (38%) or congen-
tal (25%). The mean follow-up duration from TGR implantation
urgery (75% single rod/25% dual rod) to last follow-up date was
.4 ± 2.9 years.: Surgery & Research 100 (2014) 469–474
The expense of medical resources due to unplanned events was
considered with limitation to growing rod fractures [12]. As this
event did not occur in our local cohort, the associated probability
was estimated based on Pubmed literature search. In case of a rod
breakage, an emergency surgery was considered to repair the rod
with a connector but assuming this would not modify the frequency
of distraction surgeries (i.e. if a rod fracture is observed 3 months
after the latest distraction surgery, a surgery would be performed
but the next distraction surgery would then occur 6 months later).
At last, other medical resource consumption were estimated
based on the interview of two  senior paediatric orthopaedic sur-
geons experienced in EOS management and included:
• spinal bracing: each patient was  considered to have one custom-
molded orthosis every 18 months;
• physiotherapy visits: each patient was considered to have one
session per week;
• medicalized transport: we  considered that 50% of patients would
require medical transportation after index surgery, and that 25%
of patients would require transportation after distraction for an
average distance of 60 km.
All the assumptions concerning medical resource expenses are
reported in Table 1.
2.2. Medical resource expenses for MCGR strategy
The use of the MCGR system called MAGEC1 was  considered for
this strategy. It consists of a growing rod that is magnetically driv-
able once implanted using a hand-held magnetic external remote
controller placed on the patient’s back [4] allowing non-invasive
distractions. This medical device was CE marked in September
2010. We  assumed its support by the French national health insur-
ance system in addition to hospital stays. The medical resource
expenses with the MAGEC system were estimated on the basis of
data from the UK experience [9] which is the largest cohort reported
so far (34 patients; 13 boys/21 girls; mean age at ﬁrst surgery:
8 years; mean follow-up: 15 months) as well as data from our local
experience on the use of this device (5 patients, 4 boys/1 girl, mean
age at ﬁrst surgery: 9.7 years; mean follow-up: 8 months). As for
TGR, we considered an initial implantation surgery using single
MCGR in 75% of cases and dual MCGR in 25% of cases plus conven-
tional instrumentation (including screws, hooks, and connectors).
After index surgery, medical expenses were medical outpatient
distraction visits and full spine radiographs using EOS low dose
imaging system. The capacity of MCGR to maintain spinal curva-
ture over time after outpatient distraction visits has been described
in published data up to 2 years. We  considered this efﬁcacy main-
tained between years of follow-up three and four on the basis of
clinical experience from UK specialists.
As for TGR, the expense of medical resources due to unplanned
events was  considered with limitation to growing rod fractures and
was estimated based on the data from the UK experience. In case
of a rod breakage, an emergency surgery was considered to repair
the rod with a connector adding one surgery to the management
of patients.
At last, the same assumptions as the one of TGR strategy werereported in Table 1.
1 Ellipse MAGECTM Spinal System, Ellipse Technologies, DB2C France.
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Table  1
Base case values of medical resource parameters and ranges for sensitivity analysis.
Medical resource consumption Base case Source Range for sensitivity analysis
Minimum Source Maximum Source
TGR strategy
Surgeries (including initial implantation) (per patient-year) 2.3 LC 1.9 LC 2.6 LC
Medical visits (per patient-year) 2.5 LC 1.9 LC 3.4 LC
Vertebral radiographs (per patient-year) 2.8 LC 1.9 LC 3.9 LC
Rod  fracture (%/year) 3.6 [12] 2.7 EI 4.5 EI
MCGR strategy
Outpatient distraction visit (per patient-year) 6 LC 3.8 [9] 8 EI
Vertebral radiographs (frequency per year) 6 LC None applied 12 EI
Rod  fracture (%/year) 4.7 [9] 3.5 EI 5.8 EI
TGR  and MCGR surgery
Single rod/dual rod at index surgery (mean proportion) 0.75/0.25 LC 0.5/0.5 EI 1/0 EI
Screws/hooks (mean number at index surgery) 2.5/3.75 LC None applied None applied
Spinal  bracing (frequency of replacement) 1 per 18 month EI None applied None applied
Physiotherapy visits (frequency) 1 per week EI None applied None applied
Medical  transportation
After index surgery (% of beneﬁting patient) 50 EI None applied None applied
M ta bas
2
f
•
•
•
T
B
MAfter  distraction (% of beneﬁting patient) 25 
CGR: magnetically controlled growing rods; TGR: traditional growing rod; LC: da
.3. Economic valorisation of medical resource
The costs of medical resources consumed were calculated on the
ollowing basis:
hospital stays: ofﬁcial Diagnosis-Related Groups (DGRs)’s tariffs
for scoliosis surgery (cost of standard hospital stay with low-
grade of severity: 4313 D, cost of standard hospital stay with
mid-grade of severity: 5763 D) were considered;
implantable medical devices: costs were estimated based on ofﬁ-
cial fares knowing that conventional devices are reimbursed in
addition to hospital stay tariffs, depending on the type of con-
struct (rod: 78 D per unit, screw: 185 D per unit, hook: 154 D per
unit, connector: 73 D per unit); for MCGR, we considered the cur-
rent French tariffs for the MAGEC system: 22,772 D for a single
MCGR, and 33,404 D for dual MGCGs; those tariffs include the
provision of the external remote controller by the French distrib-
utor;
spinal bracing: ofﬁcial fares were taken into account (1018 D for
orthosis and the molding);
able 2
ase case values of costs.
Medical resource consumption Base case 
Hospital stays
Standard hospital stay with mid-grade of severity 5763 
Standard hospital stay with low-grade of severity 4315 
Medical devices
Single traditional rod (TGR) 78 
Single MCGRa 22, 772 
Dual  MCGRa 33, 404 
Screw 185 
Hook 154 
Connector 73 
Spinal bracing (orthosis and moulding) 1018 
Other
Medical visits 23 
Physiotherapy visits 27 
Full  spine radiographs 57 
Medicalized transportation 66 
CGR: magnetically controlled growing rods; TGR: traditional growing rod.
a Including the provision of the external remote controller by the French distributor foEI None applied None applied
ed from our centre; EI: value based from expert interview.
• medical and physiotherapy visits: costs were valued according to
the French nomenclature rate (23 D for medical visits and 27 D for
physiotherapy visits);
• full spine radiographs: costs were valued according to the French
nomenclature rate (57 D);
• medical transportation: cost was estimated taking into account
the most frequently observed proportion of transportation modes
[ambulance (42%) – sanitary vehicle (23%) – taxi (31%) – or other
(4%)]. The average distance limit between the institution and the
patient’s home was  set at 30 km,  corresponding to a mean trans-
portation cost of 66 D.
All the values for costs are reported in Table 2.
2.4. Statistical analysis and sensitivity analysisThe incremental cost was calculated as the difference between
the cost of MCGR and the cost of TGR. The effect of time horizon
variation on cumulated costs was examined.
(D) Range for sensitivity analysis
Minimum (D) Maximum (D)
4322 7203
3237 5394
None applied
17,079 28,465
25,053 41,755
None applied
None applied
None applied
None applied
None applied
None applied
None applied
None applied
r each distraction.
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A one-way sensitivity analysis was conducted to assess the
mpact that a ﬁxed change in each parameter has on cost differential
nd was represented using a tornado diagram.
The ranges for sensivity analysis were based on documented
ata from the different cohorts whenever possible, or were cho-
en in accordance to expert interviews. In such cases, a variation
f plus or minus 25% was mostly applied to parameters. Ranges for
ensitivity analysis are listed in Table 1 for medical resource con-
umption. A sensitivity analysis was also performed for MCGR’s
ariffs (plus or minus 25%), annual discount rate (0% to 5%), and
tandard hospital stay’s tariffs (plus or minus 25%). At last, a three-
ay sensitivity analysis was performed taking into account the
hree parameters having individually the most important impact on
ncremental cost. Analyses were performed with Microsoft Excel®
010.
. Results
.1. Estimated costs for both strategies and incremental cost
On the basis of assumptions from Tables 1 and 2, the direct costs
f the standard management of patients with EOS was  estimated at
9,067 D with a time horizon at 4 years and was mainly represented
y hospital stays expenses (41,148 D per patient, 83.9%). In contrast,
eported costs of medical devices, medical visits or vertebral radio-
raphs were minor and reached respectively 1148 D (2.3%), 230 D
0.5%), and 638 D (1.3%) of the total amount.
For MCGR strategy, given a time horizon of 4 years, mean direct
ost could be estimated at 42,752 D and is mainly represented by
he cost of the device (59.5%).
Based on those results, incremental cost at 4 years was esti-
ated at −6135 D.
The diagram of Fig. 1 illustrates the cumulative costs of both
trategies over time horizon: incremental cost decreases over time
from 20,146 D at year 1 to −6135 D at year 4). At 3 years, cumulative
osts between the two strategies have almost equal values and then
he trend is reversed in favour of MCGR group.
.2. Sensitivity analysis
One-way sensitivity analysis on incremental cost between TGR
nd MCGR strategies were represented in a Tornado diagram based
n assumptions previously described (Fig. 2). The vertical axis rep-
esents the incremental cost between both strategies when all
arameters are ﬁxed to the value used in the baseline analysis. From
op to bottom, parameters are ranked according to their degree of
ensitivity: the horizontal bar on top is the one with the largest
ncertainty. Parameters having the most inﬂuence on incrementalg rod and magnetically controlled growing rod strategies.
cost include: tariffs of hospital stays, tariffs of the MCGR, fre-
quency of distraction surgeries, and use of single or dual vertebral
installation. For those four variables, the amplitudes of incremen-
tal cost variation were 16,577 D, 12,715 D, 11,491 D, and 5277 D,
respectively. At exception of the tariffs of hospital stays, the dia-
gram shows that the variation of parameters one by one does not
reverse the trend. When considering the most pessimistic scenario
(−25% for the tariffs of hospital stays, +25% for the tariffs of MCGR,
and a frequency of distraction surgeries of 1.9 per patient-year),
the three-way sensitivity analysis estimated the incremental cost
between MCGR and TGR strategies at 13,268 D. In contrast, when
considering the most-optimistic scenario (+25% for the tariffs of
hospital stays, −25% for the tariffs of MCGR, and a frequency of dis-
traction surgeries of 2.6 per patient-year), the incremental cost was
estimated at −27,108 D.
4. Discussion
MCGR system is a promising technique in the management of
EOS with severe curvature. Its capacity to enable non-invasive dis-
traction was  ﬁrst demonstrated in a porcine model [8].
In the ﬁrst clinical case study, Cheung et al. reported encourag-
ing results on the use of MCGR showing good efﬁcacy and tolerance
in two  patients followed up to 2 years [4]. More recently, Dannawi
et al. reported technical and clinical outcomes of MCGR in 34 EOS
children in a prospective study, which was able to conﬁrm the
device efﬁcacy in stabilizing the curvature scoliosis after a mean
follow-up duration of 15 months. Furthermore, the rate of severe
complications was  very low [9].
Within the scope of the recent commercialization of a MCGR  sys-
tem in Europe and the growing interest of this technique in France
(more than 20 national cases performed as of September 2013),
our objective was  to assess and compare the direct costs associated
with the management of EOS using TGR or MCGR.
One of the main reasons to conduct this cost study was to con-
vince our health authorities to consider reimbursement of this
technique. Indeed, the current unit cost of MCGR in France (from
23,000 to 33,000 D depending on the type of spinal construct) is
much higher than the one mentioned in the literature (about 5200 D
in the Chinese report) [4,13]. Furthermore, as MCGR are not yet
reimbursed by insurance plans, their use is currently supported
by hospital budgets. At last, this evaluation was justiﬁed by the
absence of any published data reporting the cost of the current gold
standard approach of severe EOS using TGR.Our study emphasizes that conventional strategy using TGR
leads to substantial costs for the French sickness fund even though
the overall economic burden is rather limited considering the rarity
of EOS cases treated surgically.
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Despite its major unit cost, our results show that the use of MCGR
ould lead to lower direct costs with a time horizon of 4 years.
The typology of medical resource consumption should be greatly
odiﬁed when using MCGR since it should avoid the need for sur-
ical distractions with TGR. Interestingly, as illustrated on Fig. 1,
CGR procedure induces a strong expense at starting, then costs
volve gradually at the difference of TGR strategy.
We believe that the choice of a four-year-time horizon for cost
stimation is consistent with child growth as well as the lengthen-
ng capacity of MCGR. Indeed, the moment of rod’s implantation
sually corresponds to the phase of slow growth, which occurs
efore the pubertal growth spurt. Over this period, the average
rowth of thoracic and lumbar spine from T1 to L5 is 14 mm per
ear (0.82 mm per year for one vertebra) [14]. When using MCGR
ystem, a reasonable strategy would be to perform non-invasive
istractions as regularly as possible in order to reduce the risk
f stiffness of elongated area which is commonly described with
GR and responsible for the law of diminishing returns [15]. In
ur practice on 5 patients that have been implanted with MCGR,
on-invasive distractions are planned every 2 months in outpatient
isit. The amplitude of distractions varies depending on the number
f vertebrae included in the spinal construct. For one vertebra, an
xtension of 0.205 mm  is performed every 2 months corresponding
o an annual lengthening of 1.23 mm:  0.82 mm of which corre-
ponds to the theoretical growth of a vertebra, and 50% of it are
ccounted to reduce progressively the spinal curvature. In our TGR
ohort, the mean number of vertebrae concerned with TGR was
.5 (range 4–14). This latest value was then taken into account
o as that simulate how MCGR could have been used in the same
ohort. Based on that, an annual lengthening of 1.23 mm per ver-
ebra would result in a total lengthening of 11.685 mm per year.
onsidering that MCGR has a maximum lengthening capacity of
8 mm,  we assume that this potential would almost be reached
ithin a four-year period.
This study has several limitations. The major one is that our
ost-comparison is not based on data obtained from a prospective,
andomized, head-to-head comparison study between TGR andensitivity on cost differential.
MCGR. This approach could bring the highest level of evidence to
support the cost-effectiveness of MCGR. However, we believe this
type of design is very unlikely to be set up due to acceptability and
feasibility issues. Indeed, EOS is a severe affection with important
associated disabilities. We assume that a study design compris-
ing for an EOS patient, after failure of an orthopaedic treatment,
two surgical strategies, one with initial surgery and a distraction
surgery every 6 months, and this other with initial surgery and
outpatient distraction visits every 2 to 3 months, would lead to a
high proportion of refusal by the patient and/or his/her family. Fur-
thermore, EOS being a rare syndrome, this low acceptability could
not guaranty the feasibility of such a study. We  also believe that
a prospective here/elsewhere study design would not be feasible
considering that many patients in centres solely proposing TGR
strategy would not give their consent to participate. Furthermore,
taking the example of French expert EOS centres, the use of MCGR
strategy has become widely predominant in the last 18 months and
so surgeon would refuse not to propose the best treatment to their
patient. To date, no prospective comparative study has been initi-
ated based on the current ClinicalTrials.gov list. As a consequence,
we performed a cost-comparison based on a simulation model
using assumptions obtained from literature search or our local
experience. Even though the costs that we describe may  sound the-
oretical or virtual, modelling is a commonly used method in health
economic evaluation as indicated in the methodological guide from
the French National Authority for Health [11].
Other limitations may  be emphasized. First, we  did not take
into account outpatient direct costs such as drugs or medical visits.
Secondly, indirect costs, such as parents’ time off work are worth
considering but are complicated to estimate. Furthermore, a longer
time horizon evaluation could be interesting until spinal fusion is
achieved. The lack of published data on long-term evaluation of
patients treated with MCGR leads us to assume that the capacity
of MCGR to maintain spinal curvature during years 3 and 4 would
be maintained. This has to be conﬁrmed by further investigations.
At last, the costs associated with skin infections were not consid-
ered for both strategies. The reason is that we considered that this
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vent could not be correctly estimated in the MCGR because the
argest report from the UK experience solely mentioned 2 cases
f superﬁcial wound infection out of 34 patients and no deep
ound infection. However, this event being mainly a complication
f surgery, it is expected that the rate of wound infections, as well
s its associated costs, should be highly decreased by the use of
CGR.
Very little is known about mechanical possibilities of the device,
nd its ability to extend reliably and regularly. Some differences
etween the theoretical lengthening indicated on the external
emote controller and lengthening really obtained measured on
adiographs have already been identiﬁed in our center, which varies
reatly depending on corpulence of the patient and stiffness of
pinal deformity. Our protocol is therefore a theoretical basis land-
ark that will evolve gradually with the use of MCGR in our centre.
MCGR technique is expected to reduce the spinal curvature and
o maintain it during growth thanks to frequent growth related
istraction, while avoiding iterative surgeries. Considering the
atient’s quality of life, this new approach could overpass the
old standard treatment using TGR. Therefore, cost-utility studies
ncluding quality of life measurement using the EOS questionnaire
16] should be of great interest but such an approach would neces-
itate a prospective head-to-head comparison, which seems to be
nlikely as previously discussed. However, improvement of quality
f life could be indirectly evaluated considering that about 2 sur-
eries and hospital stays per patient-year could be avoided using
CGR.
Although the expected medical beneﬁt of this novel technology
s tremendous, long-term perspective on MCGR efﬁcacy is cur-
ently lacking which is of particularly importance knowing that EOS
atients are usually treated for a long period before spinal fusion
s indicated. Our study provides original data on a rare pathology
nd provides economic support on an expansive management. If
he effectiveness of MCGR is further conﬁrmed, this could be one
f those preferable situations in which a breakthrough technology
roves cost saving.
. Conclusion
The management of severe EOS using conventional growth rods
s characterized by a substantial cost per patient due to the itera-
ive distraction surgeries and associated hospital stays. Moreover,
espite its efﬁcacy to control the deformity, high complication rates
re reported proportionally to the number of distraction surger-
es. This speciﬁc morbidity advocates for non-invasive distraction
echniques. In this indication, the use of magnetically controlled
[: Surgery & Research 100 (2014) 469–474
growing rods is promising and despite its high unit cost, further
clinical studies should be encouraged to conﬁrm the potential cost-
effectiveness of this innovative technique.
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